92 related articles for article (PubMed ID: 19238030)
1. Intraductal tubular carcinoma of the pancreas: case report with molecular analysis.
Furukawa T; Hatori T; Fukuda A; Fujita I; Yamamoto M
Pancreas; 2009 Mar; 38(2):235-7. PubMed ID: 19238030
[No Abstract] [Full Text] [Related]
2. Optimizing methods for the diagnosis of pancreatic cancer.
Brugge WR
J Clin Gastroenterol; 2007; 41(10):869-70. PubMed ID: 18090153
[No Abstract] [Full Text] [Related]
3. Simple mucinous cyst: another potential cancer precursor in the pancreas? Case report with molecular characterization and systematic review of the literature.
Milanetto AC; Tonello AS; Valotto G; Munari G; Luchini C; Fassan M; Pasquali C
Virchows Arch; 2021 Jul; 479(1):179-189. PubMed ID: 33511431
[TBL] [Abstract][Full Text] [Related]
4. Use of predictive markers in oncology: are phase 3 trials always required?
Markman M
Oncology; 2011; 81(1):1-2. PubMed ID: 21894048
[No Abstract] [Full Text] [Related]
5. Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method.
Rückert F; Aust D; Böhme I; Werner K; Brandt A; Diamandis EP; Krautz C; Hering S; Saeger HD; Grützmann R; Pilarsky C
J Surg Res; 2012 Jan; 172(1):29-39. PubMed ID: 21683373
[TBL] [Abstract][Full Text] [Related]
6. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma.
Brody JR; Costantino CL; Potoczek M; Cozzitorto J; McCue P; Yeo CJ; Hruban RH; Witkiewicz AK
Mod Pathol; 2009 May; 22(5):651-9. PubMed ID: 19270646
[TBL] [Abstract][Full Text] [Related]
7. Intraductal carcinosarcoma with a heterologous mesenchymal component originating in intraductal papillary-mucinous carcinoma (IPMC) of the pancreas with both carcinoma and osteosarcoma cells arising from IPMC cells.
Okamura J; Sekine S; Nara S; Ojima H; Shimada K; Kanai Y; Hiraoka N
J Clin Pathol; 2010 Mar; 63(3):266-9. PubMed ID: 20203229
[TBL] [Abstract][Full Text] [Related]
8. Translational research in pancreatic cancer: KRAS and beyond.
Boeck S; Ormanns S; Haas M; Bächmann S; Laubender RP; Siveke JT; Jung A; Kirchner T; Heinemann V
Pancreas; 2014 Jan; 43(1):150-2. PubMed ID: 24326376
[No Abstract] [Full Text] [Related]
9. Biological identification of ampullary adenocarcinomas.
Relias V; Saif MW
JOP; 2014 Jul; 15(4):306-7. PubMed ID: 25076327
[TBL] [Abstract][Full Text] [Related]
10. Evolution and dynamics of pancreatic cancer progression.
Yachida S; Iacobuzio-Donahue CA
Oncogene; 2013 Nov; 32(45):5253-60. PubMed ID: 23416985
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic adenocarcinoma.
Ryan DP; Hong TS; Bardeesy N
N Engl J Med; 2014 Sep; 371(11):1039-49. PubMed ID: 25207767
[No Abstract] [Full Text] [Related]
12. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
[TBL] [Abstract][Full Text] [Related]
13. [Genetic aspects of pancreatic cancer].
Grigor'eva IN; Efimova OV; Suvorova TS; Tov NL
Eksp Klin Gastroenterol; 2014; (10):70-6. PubMed ID: 25911935
[TBL] [Abstract][Full Text] [Related]
14. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.
Iacobuzio-Donahue CA; Fu B; Yachida S; Luo M; Abe H; Henderson CM; Vilardell F; Wang Z; Keller JW; Banerjee P; Herman JM; Cameron JL; Yeo CJ; Halushka MK; Eshleman JR; Raben M; Klein AP; Hruban RH; Hidalgo M; Laheru D
J Clin Oncol; 2009 Apr; 27(11):1806-13. PubMed ID: 19273710
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
[TBL] [Abstract][Full Text] [Related]
16. Intraductal tubular carcinoma of the pancreas: a case report with the imaging findings.
Oh DK; Kim SH; Choi SH; Jang KT
Korean J Radiol; 2008; 9(5):473-6. PubMed ID: 18838860
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
Hepatogastroenterology; 2001; 48(39):879-83. PubMed ID: 11462947
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic adenocarcinosarcoma of monoclonal origin: a case report.
Kim HS; Kim JI; Jeong M; Seo JH; Kim IK; Cheung DY; Kim TJ; Kang CS
World J Gastroenterol; 2014 Sep; 20(35):12682-6. PubMed ID: 25253976
[TBL] [Abstract][Full Text] [Related]
19. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
[TBL] [Abstract][Full Text] [Related]
20. Phenotype and genotype of pancreatic cancer cell lines.
Deer EL; González-Hernández J; Coursen JD; Shea JE; Ngatia J; Scaife CL; Firpo MA; Mulvihill SJ
Pancreas; 2010 May; 39(4):425-35. PubMed ID: 20418756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
